glp-1 news today 2025 november 6 🚨 Breaking in Obesity Care! 🚨 President Trump just announced major deals with Eli Lilly and Novo Nordisk — the makers of Mounjaro, Zepbound, Wegovy, and Ozempic — to slash weight Pfizer GLP-1 weight loss drug

some telehealth companies have vetting protocols that differ on a state-by-state basis, to comply with laws

Someone stopping these medications doesnt have the same control over their obesity, and their weight can increase. What to expect Nearly 12% of Americans about one in eight have used GLP-1 drugs for weight loss, according to a 2025 report from RAND, a nonprofit research organization

However, several considerations cast doubt on the endocrine mechanism of the GLP-1

For weight management specifically, the FDA has approved several GLP-1 medications at higher doses than those used for diabetes treatment

I think a lot of companies we're going to see maybe shifting away from this custom approach because they are afraid that the FDA could come in any day and shut them down and say you can't do this anymore. George Ball, Indiana University associate professor of operations and decision technologies, has a different take on the situation

Effects of Insulin-like Growth Factors (IGF) on Pancreatic Islet Function in IGF Binding Protein-1 Transgenic Mice